Calton & Associates, Inc. Moderna, Inc. Transaction History

Calton & Associates, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 13, 2022	SELL	$225.82 - $368.51 $507,417 - $828,041	-2,247 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$221.9 - $484.47 $191,277 - $417,613	-862 Reduced 27.73%	2,247 $865,000
Q2 2021 Aug 11, 2021	SELL	$129.91 - $234.98 $20,525 - $37,126	-158 Reduced 4.84%	3,109 $731,000
Q1 2021 May 03, 2021	BUY	$109.18 - $185.98 $982 - $1,673	9 Added 0.28%	3,267 $428,000
Q4 2020 Jan 25, 2021	BUY	$65.74 - $169.86 $15,974 - $41,275	243 Added 8.06%	3,258 $340,000
Q3 2020 Oct 30, 2020	SELL	$54.34 - $94.85 $36,081 - $62,980	-664 Reduced 18.05%	3,015 $213,000
Q2 2020 Aug 10, 2020	BUY	$29.67 - $80.0 $109,155 - $294,320	3,679 New	3,679 $236,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Calton & Associates, Inc. with notifications on news.